Seven questions about LifeArc’s 2030 ambitions
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics
How can we reduce the impact of dementia on individuals, families and wider society?
Melanie Lee on how bringing together diverse teams united under a clear purpose can deliver extraordinary results.
Together with the patient charity Motor Neurone Disease (MND) Association, LifeArc co-sponsored an MND challenge within a…
Unique translational research hub for Covid-19 and other viruses was a finalist in the Scottish Knowledge Exchange Awards.